Streptomyces global regulators AfsR and AfsS interact to co‐regulate antibiotic production and morphological development
Microbial Biotechnology · 2024
DOI: 10.1111/1751-7915.14319 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbial Biotechnology, 2024. Verfasst von Yi Hao und 3 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Animal Biotech Breeding and College of Biological Sciences, China Agricultural University, Beijing, China. Hauptthemen laut MEDLINE: Transcription Factors, Streptomyces. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Streptomyces species have a complex life cycle and are the producers of ~70% of commercial antibiotics. Global regulators AfsR and AfsS are widespread among Streptomyces and have been identified as key activators of antibiotic production in several species. However, their roles as repressors of antibiotic production are unclear; in particular, nothing is known regarding the regulatory mechanism of AfsS, despite many decades of research, because it has no DNA‐binding domain. Here, we demonstrate that AfsR and AfsS negatively regulate avermectin production and morphological development in the industrially important species S. avermitilis . AfsR directly represses ave structural genes ( aveA1 , aveA4 ), cluster‐situated activator gene aveR , and eight key developmental genes, whereas it directly activates afsS , aco (for autoregulator avenolide biosynthesis), and avaR1 (encoding avenolide receptor). GST pull‐down, microscale thermophoresis, co‐immunoprecipitation, and chromatin immunoprecipitation‐quantitative PCR assays demonstrated that AfsS interacts with AfsR to co‐regulate target genes involved in avermectin production and development and that this interaction requires intact AfsS repeated sequences and enhances the binding affinity of AfsR to target promoters. AfsR/AfsS interaction also occurs in model species S. coelicolor and S. roseosporus (producer of daptomycin, a cyclic lipopeptide antibiotic widely used for the treatment of human infections), suggesting that such interaction is conserved in Streptomyces species. The master developmental repressor BldD acts as a direct activator of both afsR and afsS . Deletion of afsR or afsS strongly enhances avermectin production in wild‐type and industrial S. avermitilis strains. Our findings demonstrate novel regulatory roles and mechanisms of AfsR and AfsS in Streptomyces and facilitate methods for antibiotic overproduction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Animal Biotech Breeding and College of Biological Sciences, China Agricultural University, Beijing, China.
ORCID-Profile: Ying Wen
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
Hao, Y., Liu, W., Li, X., & Wen, Y. (2024). Streptomyces global regulators AfsR and AfsS interact to co‐regulate antibiotic production and morphological development. Microbial Biotechnology. https://doi.org/10.1111/1751-7915.14319
Vancouver
Hao Y, Liu W, Li X, Wen Y. Streptomyces global regulators AfsR and AfsS interact to co‐regulate antibiotic production and morphological development. Microbial Biotechnology. 2024. doi:10.1111/1751-7915.14319
BibTeX
@article{Hao2024,
author = {Hao, Yi and Liu, Wenshuai and Li, Xingwang and Wen, Ying},
title = {Streptomyces global regulators AfsR and AfsS interact to co‐regulate antibiotic production and morphological development},
journal = {Microbial Biotechnology},
year = {2024},
doi = {10.1111/1751-7915.14319}
}
EUVIMED